Twist Bioscience's Chief Legal: What Investors Need to Know
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
A comprehensive zero based budget checklist can help you stay on track. Use it to ensure you don’t miss any budgeting steps.
17,508 articlesA senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
As AI startups eye the public markets, anthropic goes public trillion could unlock a new wave of investor opportuniti...
Copart director Daniel Englander recently sold 80,000 shares for about $2.2 million. With CPRT down roughly 40%, inve...
Markets open with caution as AI jitters mix with Middle East tensions. This article breaks down what this means for y...
Two popular U.S. tech ETFs—VGT and FTEC—often attract the same investor despite different price tags on cost and liqu...
Dive into Hamilton Lane's 2026 outlook with a clear, investor-focused breakdown. We explore revenue drivers, AUM grow...
Investors often chase the crowd, but a disciplined big-picture trade can balance momentum with risk. This guide shows...
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
When a tech CEO sells stock, investors pay attention. This article breaks down the implications of Adobe CEO Shantanu...
A straightforward, discipline-driven strategy suggests buying three Vanguard index funds to potentially outperform th...
When a company's CFO divests shares amid a strong stock run, investors want to know what it means. This deep dive exp...
A major fund disclosed a $38 million stake in monday.com as the stock collapsed by about 75%. This article explains w...